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Available online 23 April 2013Improper protein folding or aggregation can frequently be responsible for low expression and poor
functional activity of antibody fragments secreted into the Escherichia coli periplasm. Expression
issues also can affect selection of antibody candidates from phage libraries, since antibody
fragments displayed on phage also are secreted into the E. coli periplasm. To improve secretion of
properly folded antibody fragments into the periplasm, we have developed a novel approach that
involves co-expressing the antibody fragments with the peptidyl prolyl cis-trans isomerase, FkpA,
lacking its signal sequence (cytFkpA) which consequently is expressed in the E. coli cytosol.
Cytoplasmic expression of cytFkpA improved secretion of functional Fab fragments into the
periplasm, exceeding even the benefits from co-expressing Fab fragments with native, FkpA
localized in the periplasm. In addition, panning and subsequent screening of large Fab and scFv
naïve phage libraries in the presence of cytFkpA significantly increased the number of unique
clones selected, as well as their functional expression levels and diversity.
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r B.V. Open access under CC BYby co-expressing them with molecular chaperones or folding
catalysts (Bothmann and Pluckthun, 1998; Strachan et al.,
1999; Bothmann and Pluckthun, 2000; Levy et al., 2001;
Mavrangelos et al., 2001; Maynard et al., 2005). The correct
folding of scFv and Fab antibody fragments is highly dependent
on the activity of peptidyl prolyl cis-trans isomerases (PPIases).
Following the formation of variable and constant domain
intra-chain disulphide bonds, peptidyl prolyl cis-trans isomer-
ization reactions drive folding into the native conformation,
allowing formation of the interchain disulphide bonds. PPIases
also prevent aggregation of antibody fragments (Feige et al.,
2010). Kappa light chain variable domains (Vκ) contain two
conserved prolines in the cis conformation at positions L8 and
L95 (Bothmannand Pluckthun, 2000) unlike the frameworks of
heavy chain variable (VH) and lambda light chain variable (Vλ)
antibody domains which, based on evaluation of sequences in
the PDB database, do not contain any cis-prolines (Horne and
Young, 1995). Cis-trans isomerization at Pro-L95 is a rate
limiting step in the folding of Vκ domains and is essential for
VL/VH docking and therefore for native protein conformation license.
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et al., 1997; Ramm and Pluckthun, 2000). Interestingly, co-
expression of the periplasmic Escherichia coli PPIase, FkpA,
resulted in a significant improvement in secretion into the
bacterial periplasm of functional scFv fragments containing
either Vκ chains, which contain cis prolines, or Vλ chains which
donot contain cis-prolines, suggesting that it has bothmolecular
chaperone and PPIase enzymatic activities (Bothmann and
Pluckthun, 2000). Employing FkpA deletion mutants and func-
tional assays, Saul et al. (2004) established that the FkpA
carboxy and amino terminal domains carry independent PPIase
and chaperone activities, respectively.
Previously, Missiakas et al. (1996) demonstrated that FkpA
can act as a “global folding catalyst” that limits the levels of
unfolded proteins in the outer membrane and periplasm.
Periplasmic overexpression of FkpA facilitates the expression of
multiple heterologous proteins, including an E. coli maltose
binding protein misfolding mutant (Arie et al., 2001), single-
chain antibodies and antibody fusions (Arie et al., 2001;
Zhang et al., 2003; Padiolleau-Lefevre et al., 2006; Sonoda et
al., 2010).
Another molecular chaperone in the E. coli periplasm is the
17 kDa Skp protein which forms a trimer with a central cavity.
This cavity allows Skp to engulf native polypeptide substrates
and prevents their subsequent aggregation (Walton et al., 2009).
Co-expression of Skp with a poorly soluble single chain Ab
resulted in its secretion into the E. coli periplasm as well as
improved solubility and phage display of the antibody fragment
and diminished the toxicity of the antibody for the host cells
(Hayhurst and Harris, 1999). As observed with FkpA, other
groups have demonstrated that co-expression of scFvs with
Skp increased their secretion in E. coli (Sonoda et al., 2010).
Previously, it also was shown that overexpression of Skp
lacking its signal sequence significantly improved the yield of a
correctly folded Fab produced by a trxBgormutant E. coli strain
that enables the production of disulphide bonds in the bacterial
cytoplasm (Levy et al., 2001).
We report here improvement in functional Fab expression
into the E. coli periplasm as a result of its co-expression with
FkpA lacking a signal sequence (cytFkpA). The secretion of
active Fabs into the periplasmwas higher when co-expressed
with cytFkpA either on a separate vector under control of an
L-arabinose-inducible promoter, or as part of a tricistronic
message that includes the chaperone, Fd and light chains on a
single plasmid. We also examined the effect of cytFkpA
expression on selection of scFv or Fab candidates from large
phage libraries and have demonstrated increased expression
levels and diversity of displayed antibodies targeting the
selected antigens, resulting in selection of a larger number of
functional, sequence-unique antibody fragments with slower
dissociation constants.2. Materials and methods
2.1. Strains
XL1-Blue cells (recA1 endA1 gyrA96 thi-1 hsdR17 supE44
relA1 lac [F′ proAB lacIqZΔM15 Tn10 (Tetr)]) and TG1 cells (supE
thi-1Δ(lac-proAB)Δ(mcrB-hsdSM)5 (rK-mK–) [F′ traD36 proAB
lacIqZΔM15]) were purchased from Agilent (Santa Clara, CA).2.2. Plasmids expressing bacterial chaperones
In order to generate the plasmids responsible for
cytoplasmic expression of chaperones, the native signal
sequences were excised from the genes encoding the
chaperones FkpA (Swiss-Prot accession no. P65764) and
Skp (Swiss-Prot accession no. P0AEU7). Chaperones were
also allowed to express in the bacterial periplasm with their
native signal sequences. To generate the plasmid constructs
of the cytoplasmic or periplasmic versions of the chaperones
Skp and FkpA, and the bicistronic Skp-FkpA, the chaperone
gene fragments were amplified by PCR and then cloned into
the plasmid vector pAR3 (ATCC accession no. 87026). The
vector pAR3 (Perez-Perez and Gutierrez, 1995) contains the
pBAD promoter and the cat gene which confers chloram-
phenicol antibiotic resistance. This plasmid harbors the p15A
origin of replication which is compatible with the origin
ColE1 included in all the vectors co-expressing Fabs or scFvs
in our experiments. Two different forward primers and one
reverse primer were designed in order to amplify FkpA from
XL-1Blue cells by PCR amplification with or without the
native leader peptide. Similarly, two forward primers and
one reverse primer were designed to amplify Skp from
XL1Blue cells by PCR with or without its native signal
sequence.
To generate the chaperone plasmid constructs pAR3-FkpA
and pAR3-Skp for periplasmic expression and pAR3-cytFkpA
and pAR3-cytSkp for cytoplasmic expression, the products of
the previous PCR reactions were used as templates for PCR
re-amplification using forward primers to incorporate a BglII
restriction site followed by the enhancer sequence GAATTCA
TTAAAGAGGAGAAATTAACT upstream from the chaperone
encoding gene fragment. Reverse primers were used to
incorporate the V5 tag sequence (GGTAAGCCTATCCCTAACC
CTCTCCTCGGTCTCGATTCTACG) into pAR3-Skp andpAR3-cytSkp
and the FLAG tag sequence (GACTACAAGGACGATGACGACAAG)
into the pAR3-FkpA and pAR3-cytFkpA, followed by the re-
striction site HindIII.
To generate the bicistronic periplasmic pAR3-[Skp +
FkpA] and cytoplasmic pAR3-cyt[Skp + FkpA] constructs,
the monocistronic PCR products were reamplified. To
reamplify Skp, forward primers were used to incorporate
BglII, followed by the enhancer GAATTCATTAAAGAGGAGA
AATTAACT and the periplasmic or cytoplasmic versions of
Skp. A reverse primer was designed that anneals to the entire
V5 sequence and to an optimized Shine–Dalgarno (SD)
sequence driving the translation initiation of FkpA. To
reamplify FkpA, forward primers were designed to anneal
to the C-terminal portion of V5, the optimized SD, and the
periplasmic or cytoplasmic versions of FkpA. A reverse
primer was designed to add a HindIII-FLAG tag sequence to
the C-terminal portion of FkpA. The Skp and FkpA PCR
products were then gel-purified using Qiagen gel extraction
kits (Valencia, CA) and used as templates for an overlap
extension PCR reaction using the external forward Skp
primer and an external reverse FkpA primer. Fig. 1a illus-
trates the resulting chaperone inserts. Ligations of the BglII–
HindIII digested PCR products to the BglII–HindIII digested
pAR3 vector were then transformed by electroporation into
XL1-Blue cells. The final constructs were confirmed by DNA
sequencing.
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Fig. 1. Chaperone constructs utilized in this study. (a) Monocistronic vectors expressing the chaperones cytSkp, cytFkpA, and cyt[Skp + FkpA] in the E. coli
cytoplasm and Skp, FkpA, and [Skp + FkpA] expressed in the periplasm. Gene constructs were cloned into the multi-cloning site of the arabinose-inducible vector
pAR3 (Perez-Perez and Gutierrez, 1995) between the BglII and HindIII restriction sites. (b) Tricistronic vector expressing the light chain (VL-CL) and heavy chain
(VH-CH) of the human anti-EpCAM Fab ING1 with a C-terminal 6His-cmyc-V5 Tag (HMV) in the periplasm via DNA signal sequences (ss) together with the
cytFkpA that carries a C-terminal FLAG tag. The tricistronic construct was then cloned into a lac-inducible phagemid described in the Materials and methods
section. The ends of open reading frames are depicted by open circles.
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All Fabs and scFv fragments used in this work were cloned
into proprietary phagemid vectors (Schwimmer et al., 2013)
harboring a triple 6His-cmyc-V5 tag, the beta lactamase gene
conferring ampicillin resistance and the ColE1 origin of
replication that is compatible with the p15A origin of the
pAR3 vector (backbone for chaperone expressing vectors).
The Fabs with kappa light chains used were: a) XPA23
(anti-IL1β, human), b) ING1 (anti-EpCAM, human), c) 83-7
(anti-human insulin receptor (huINSR), murine), d) CF1
(anti-Tie-1, human), and e) BM7-2 (anti-kinase, human).
We also tested the lambda light chain containing gastrin-
specific Fabs C10, D1, and E6. The antigens huINSR, Tie-1-Fc,
and IL1β were purchased from R&D Systems (Minneapolis,
MN).
2.4. Tricistronic vector expressing ING1 Fab and cytFkpA
In the phagemid vector expressing the ING1 Fab in the E.
coli periplasm under the influence of the lac promoter, the
gene fragment encoding the M13 phage pIII protein was
replaced with cytFkpA. In order to produce the tricistronic
construct (Fig. 1b), two non-amber stop codons were added
following the triple detection tag 6His-cmyc-V5. The gene
fragment cytFkpA was amplified by PCR from the vector
pAR3-cytFkpA, together with an upstream enhancer se-
quence and C-terminal FLAG tag. The final construct was
cloned into the modified phagemid expressing the ING1 Fab.
2.5. Preparation of cytoplasmic and periplasmic E. coli extracts
TG1 electroporation-competent cells were co-transformed
with the Fab expressing vectors that were previously described
alongwith one of the chaperone-expressing vectors pAR3-FkpA,
pAR3-Skp, pAR3-cytFkpA, pAR3-cytSkp, or the bicistronic pAR3-
[Skp + FkpA], and pAR3-cyt[Skp + FkpA]. Co-expression ofthe Fab-expressing vectors with the empty plasmid pAR3
served as a negative control.
In order to prepare cytoplasmic and periplasmic extracts
expressing the chaperones alone, TG1 cells carrying the empty
pAR3 plasmid (negative control) or the chaperone-expressing
plasmid constructs were grown overnight at 37 °C in 2YT
growth media supplemented with 34 μg/ml chloramphenicol
and 2% (w/v) glucose until the OD600 reached 0.5. The
expression of chaperones was then induced with 0.2%
arabinose (w/v) at 30 °C overnight. At that point, the OD600
was recorded and cultureswere normalized to the sameOD600.
Cells were pelleted and resuspended in 10 ml ice-cold PPB
buffer (30 mM Tris–HCl, pH 8.0, 1 mM EDTA, 20% sucrose)
(Teknova, CA) at 1:4 dilution. Following incubation at 4 °C for
1 h, samples were centrifuged for 30 min and supernatants
containing the periplasmic extracts were collected. Pellets
were resuspended in 10 ml BugBuster® solution (Novagen, NJ)
supplemented with one tablet of complete EDTA-free protease
inhibitor cocktail (Roche, IN) and 2500 units benzonase
nuclease (Novagen) in order to reduce the viscosity of the
lysates. Following 1 hour incubation in ice, lysates were
centrifuged at 16,000 g for 20 min at 4 °C and supernatants
containing the cytoplasmic extracts were collected.
To prepare periplasmic extracts of cells expressing Fabs
together with the chaperones, TG1 cells harboring the Fab
and chaperone plasmid constructs (or pAR3 alone as negative
control) were grown overnight at 37 °C in 2YT growth media
supplemented with 34 μg/ml chloramphenicol, 100 μg/ml
carbenicillin and 2% (w/v) glucose and subcultured in 100 ml
flasks at 37 °C until the OD600 reached 0.5. Thirty minutes
after the addition of 0.2% arabinose (w/v), isopropyl β-D-1-
thiogalactopyranoside (IPTG) was added to a final concen-
tration of 1 mM and cultures were incubated overnight at
30 °C. At that point the OD600 was recorded and cultures
were normalized to equal OD600. Cells were pelleted and
resuspended in 10 ml ice-cold PPB sucrose buffer (Teknova)
at 1:4 dilution and one tablet of complete EDTA-free protease
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1 h, samples were centrifuged for 30 min and the superna-
tants containing the periplasmic extracts were collected.
Similarly, periplasmic extracts from TG1 cells expressing the
ING1 Fab and cytFkpA from a single tricistronic vector were
generated without chloramphenicol selection (only with
carbenicillin) and simultaneous induction of ING1 Fab and
cytFkpA with 1 mM IPTG.
2.6. Western blotting
Samples of periplasmic and cytoplasmic extracts were
resuspended in SDS loading buffer with 0.7 M beta-
mercaptoethanol, boiled and loaded in NuPAGE® 4–12% Bis–
Tris precast gels (Invitrogen, CA) using NuPAGE MOPS SDS
running buffer (Invitrogen). Proteins from reduced gels were
then transferred to PVDF membranes using the Millipore-
SNAP-i.d.® electroblotter (Millipore, CA). The membranes
were blocked with 0.5% BSA/PBS and incubated for 15 min at
room temperaturewithmouse anti-V5 antibodies (Sigma,MO)
at 1:2000 dilution for the detection of Skp or with murine
anti-FLAG primary antibodies (Sigma) at 1:1000 dilution in
0.5% BSA/PBS for the detection of FkpA. Subsequently, primary
antibodies were detected with goat anti-mouse IgG (H + L)
conjugated with horseradish peroxidase (HRP) (Jackson
Immunoresearch, PA) at a 1:2000 dilution. Color was devel-
oped with 1-Step TMB-Blotting substrate solution (Pierce, IL).
2.7. Target and expression ELISAs
The amount of functional Fab binding to target antigens was
determined by ELISA. Ninety six-well high binding MaxiSorp®
assay plates (Nunc, NY) were coated with 1–3 μg/ml antigen
diluted in phosphate buffer saline (PBS). EpCAM (bound by
ING-1 Fab), IL1β (bound by XPA23 Fab) and Tie-1-Fc (bound by
CF1 Fab) antigens were coated at 3 μg/ml. Kinase (bound by
BM7-2 Fab) was coated at 2 μg/ml. Human insulin receptor
(huINSR) (bound by 83-7 Fab) was coated at 1 μg/ml.
Biotinylated gastrin (a 14-mer peptide recognized by the C10,
D1, and E6 Fabs) was coated at 1 μg/ml in PBS on Reacti-Bind
Streptavidin-coated 96-well plates (Thermo Scientific,MN). The
coated plates were then incubated overnight at 4 °C and
blocked with 5% non-fat dry milk (Nestlé, OH) in PBS buffer
(no blocking was required for the streptavidin-coated plates).
Plate washes were carried out in PBS with 0.05% TWEEN®-20.
Dilutions of Fabs, and primary and secondary antibodies were
performed in 5% non-fat dry milk in PBS. Fabs were allowed to
bind to their blocked antigens for 1 h at room temperature. The
presence of ING1, XPA23, CF1, BM7-2, C10, D1, and E6 Fabs was
confirmed with goat-anti-human IgG [specific for F(ab′)2]
(Jackson Immunoresearch) at 1:2000 dilution, followed by
donkey anti-goat IgG (H + L) conjugated with HRP (Santa
Cruz Biotechnology, CA) at 1:10,000 dilution. The 83-7 Fab was
detected using rabbit-anti-mouse IgG [specific for F(ab′)2]
(Jackson Immunoresearch) antibodies at 1:2000 dilution,
followed by goat anti-rabbit IgG (H + L) conjugated with
horseradish peroxidase (Jackson Immunoresearch) at 1:10,000
dilution. The assay was developed with TMB soluble substrate
(EMD Chemicals, CA). The reaction was quenched with 4.5 N
H2SO4 and read at 450 nm using a SpectraMax® Plus micro-
plate reader (Molecular Devices, CA). The amount of total Fabexpressed in the periplasm was determined by ELISA. For the
detection of ING1, XPA23, BM7-2 and CF1 human kappa Fabs,
high bindingMaxiSorp 96-well plateswere coatedwith 3 μg/ml
goat-anti-human kappa IgG (Invitrogen) diluted in PBS. Simi-
larly, the murine kappa 83-7 Fab was detected with 3 μg/ml
goat-anti-mouse kappa antibodies (Jackson Immunoresearch)
and the human lambda C10, D1, and E6 Fabs with 3 μg/ml
goat-anti-human lambda IgG (Pierce). Coated plates were
incubated, blocked and washed, as previously described. Fabs
were detected using rabbit anti-V5 (Sigma) primary antibody at
1:2000 dilution, followed by goat anti-rabbit IgG (Fc-specific)
conjugated with HRP (Jackson Immunoresearch) at 1:10,000
dilution. The development of the assay was performed as pre-
viously described. ELISA data represent two biological replicate
experiments.
2.8. Quantitation of Fab by surface plasmon resonance
Quantitation of human Fab in periplasmic extracts was
performed by Surface Plasmon Resonance (SPR) on a Biacore
A4000 or Biacore 2000 instrument (GE Healthcare, NJ). A
standard curve was generated by diluting human Fab (Jackson
Immunoresearch) in two-fold serial dilutions into assay running
buffer and used for the estimation of Fab concentrations (Sup-
plementary methods, tables and figures). Fab standard and
unknowns were injected over a goat-anti-human IgG [specific
for F(ab′)2] surface (Jackson Immunoresearch) immobilized at a
high density on a Biacore CM5 Sensor chip (GEHealthcare). Data
analysis was performed using the BIAevaluation software (GE
Healthcare).
2.9. Phage panning and screening of scFv and Fab libraries
For the first round of phage panning using a naïve scFv
library (Schwimmer et al., 2013), 4.7 × 1013 cfu of phage
particles from a scFv kappa library or 1.6 × 1013 cfu of phage
particles from a Fab lambda library combined with
2.2 × 1013 cfu of phage particles from a Fab kappa library
were blocked for 1 h at RT in 5% non-fat dry milk (Marvel
Premier Foods, UK) in PBS buffer with gentle rotation. Blocked
phage was twice deselected for 45 min against streptavidin-
coated magnetic Dynabeads® M-280 (Invitrogen Dynal AS,
Oslo, Norway). The kinase antigen (R&D Systems, MN) that
was used for the scFv panning, and Tie-2 antigen (R&D
Systems) that was used for the Fab panning, were biotinylated
with Sulfo-NHS-LC-Biotin (Pierce) using the manufacturer's
protocol in 20-fold molar excess of biotin reagent and
confirmed by ELISA. The biotinylated products were then
incubated with blocked streptavidin-coated magnetic
Dynabeads® M-280 for 1 h with gentle rotation in order to
immobilize biotinylated antigen and remove unbiotinylated
material. Antigen-captured beads were then washed twice
with PBS. For the first, second and third rounds of selection,
100, 50 and 10 pmol of biotinylated kinase or Tie-2 were used,
respectively. For the first round, the deselected phage was
divided into two aliquots: one was used to infect TG1 cells, and
the otherwas used to infect TG1 cells harboring pAR3-cytFkpA.
The rescued, deselected phage was used to perform parallel
first round pannings by incubation with biotinylated kinase
streptavidin beads for 90 min at room temperature. The input
phage for rounds two and three was generated with separate
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one TG1 with pAR3-cytFkpA.
For the first round of panning, beads were washed quickly
(i.e., beads were pulled out of solution using a magnet and
resuspended in 1 ml wash buffer) three times with PBS—0.05%
TWEEN®-20, followed by three times with PBS. For the second
round of panning, beads were washed for five times with PBS—
0.05% Tween followed by one 5-minute wash. Similar washes
were performed with PBS. For the third round of panning, beads
were washed quickly for 4 times with PBS—0.05% TWEEN®-20
followed by four 5-minute washes with PBS—0.05% TWEEN®-
20. Similar washes were performed with PBS. Antigen-bound
phage was eluted via incubation for 30 min with 100 mM
triethylamine (TEA) at room temperature and subsequently
neutralized with 1M Tris–HCl (pH 7.4). The phage eluted from
each round of panning was used to infect either TG1 alone or
TG1 with pAR3-cytFkpA cells when the OD600 was equal to 0.5.
TG1 cells were grown in 2YT media and TG1 cells expressing
cytFkpA (from plasmid pAR3-cytFkpA) were grown in 2YT
media supplemented with 34 μg/ml chloramphenicol.
Following infection for 1 h at 37 °C, TG1 cells were
centrifuged and pellets were resuspended in 2YT growth
media supplemented with 100 μg/ml carbenicillin and 2%
(w/v) glucose. Resuspended cells were then plated onto 2YT
agar plates containing 100 μg/ml carbenicillin and 2% glucose
and incubated overnight at 30 °C. Similarly, TG1 cells
expressing the chaperone cytFkpA were plated onto 2YT
agar plates with 100 μg/ml carbenicillin, 34 μg/ml chloram-
phenicol and 2% glucose and incubated overnight at 30 °C.
Phage was rescued with helper phage M13K07 at a mul-
tiplicity of infection (MOI) ~20. For this purpose, first and
second round selection output clones were allowed to grow to
an OD600 ~ 0.5. At that point, cells were infected with helper
phage at 37 °C for 1 h while shaking at 100 rpm. Cell pellets
were resuspended in 2YTmedia supplementedwith 100 μg/ml
carbenicillin, 50 μg/ml kanamycin and 0.2% (w/v) arabinose
(only for TG1 cells expressing cytFkpA), and allowed to grow
overnight at 25 °C. Phage in the supernatant was recovered by
centrifugation and used for the next round of panning. In order
to estimate the enrichment resulting from the phage selections,
the amount of input and output phage was titered and plated
on 2YT agar plates supplemented with the appropriate
antibiotics.
Cloneswere picked in a 96well plate from third roundoutput
and grown in 2YT media supplemented with carbenicillin, 0.1%
glucosewith orwithout chloramphenicol at 37 °C for expression.
Induction was done by adding 1 mM IPTG. Clones from the
chaperone panning output were first induced with 0.2% arab-
inose for 30 min at 30 °C for the expression of cytFkpA, followed
by overnight induction with 1 mM IPTG at 30 °C.
The generation of periplasmic extractswas done as described
above and ELISA screening was performed using kinase or
biotinylated Tie-2 coated on MaxiSorp plates and Reacti-Bind™
streptavidin-coated 96-well plates, respectively. Only kinase-
coated plates needed to be blocked for 1 h with 5% non-fat milk
prepared in PBS. The scFv or Fab fragmentswere allowed to bind
for 1 h and 30 min to the antigen. Detection was enabled using
murine anti-V5 antibodies (1:2000) followed by goat-anti-
mouse HRP (1:10,000) (Thermoscientific, Rockford, IL). The
development and quenching of ELISAs were done as described
earlier herein.2.10. Evaluation of Fab display on the surface of M13 phage
One liter cultures of E. coli carrying phagemid vectors
expressing either lambda or kappa Fab libraries (Schwimmer et
al., 2013) in TG1 cells or TG1 cells harboring the plasmid
pAR3-cytFkpA were initiated at OD600 = 0.1. These four
cultures were grown with shaking at 250 rpm until the OD600
reached 0.5 in 2YTmedia supplemented with 2% glucose (w/v)
and 100 μg/ml carbenicillin. Chloramphenicol (34 μg/ml) was
also added to cells carrying the pAR3-cytFkpA plasmid. The
cells were then infected with M13K07 helper phage at an MOI
of 20 for 1 h at 37 °C; 30 minwithout shaking and 30 minwith
shaking at 100 rpm. After infection, the media was changed to
2YT supplemented with 100 μg/ml carbenicillin, 50 μg/ml
kanamycin, and the TG1/pAR3-cytFkpA cultures also had
34 μg/ml chloramphenicol and 0.2% (w/v) arabinose to allow
expression of cytFkpA. Samples (50 ml) were taken from each
culture 25 h after the start of the infection with helper phage.
These cultures were centrifuged and the supernatant was
heated to 60 °C to eliminate bacteria. The samples taken at
25 h were precipitated with polyethylene glycol in order to
concentrate the phage. The concentrated phage was stored in
15% glycerol at−80 °C. Serial dilutions of these samples were
made in 3% non-fat drymilk in PBS and applied for 1 h at RT to
blocked MaxiSorp plates that had been coated with anti-M13
antibodies (GE Healthcare) at 1:1000 dilution in PBS or murine
anti-V5 antibodies (Sigma) at 1:2000 dilution in PBS. The
phage was detected with anti-M13 antibodies conjugated with
HRP (GE Healthcare) at 1:5000 dilution in 3% milk/PBS for 1 h
at RT. The assay was developed by the addition of TMB soluble
substrate (KPL, MD). The reaction was quenched with 2N
H2SO4 and read at 450 nm by a SpectraMax® Plus microplate
reader. The EC50 for each set of dilutions was calculated by
fitting a sigmoidal dose response curve using GraphPad
Prism®. The relative level of Fab display was calculated by
dividing the inverse of the EC50 from the anti-V5 ELISA
(binding the V5-tag indicates the presence of a Fab molecule
displayed on a phage) by the inverse of the EC50 from the
anti-M13 ELISA and comparing each ratio to the ratio cal-
culated for the 25 hour time point of the rescue in TG1 cells.
This method is described by Soltes et al. (2003).
2.11. Determination of antibody fragment dissociation rates
using SPR
Antibody fragment screening for dissociation rate was per-
formed on a Biacore 4000. Fab fragments were screened on
ligand covalently coupled to a CM5 Series S biosensor (GE
Healthcare) via amine chemistry. Tie-2 was immobilized at
varying surface densities on spots 1 and 2 of the biosensor.
Blank spot three was used for reference subtraction. ScFv
fragments were screened utilizing capture methodology. ScFv
capture utilized monoclonal anti-V5 antibodies (Sigma). The
capture antibodywas immobilized on a CM5 Series S biosensor
by standard amine coupling. Amine couplingwas performedby
activating the chip with EDC/NHS (GE Healthcare) for 5 min
and injecting either Tie-2 or anti-V5 at 5 μg/ml in pH4.5 acetate
(GE Healthcare) for 5 min. Deactivation was performed with
1 M ethanolamine.
Periplasmic extracts of anti-Tie-2 Fabs were diluted with
equal volumes of running buffer (HBS-EP (GE Healthcare),
cytSkp-V5
cytFkpA-FLAG
1 2 3 4 5
1 2 3 4 5
17 kDa 
30 kDa 
a
b
Fig. 2. Western blots of soluble cytoplasmic (lanes 3, 5) or periplasmic
fractions (lanes 2, 4) of TG1 E. coli cells expressing cytFkpA or cytSkp alone
(lanes 2, 3) or together (lanes 4, 5) from the bicistronic construct cyt
[Skp + FkpA]. (a) Detection of cytFkpA was performed with murine
anti-FLAG mAbs. (b) Detection of cytSkp was performed with murine
anti-V5 anti-sera. Whole extract of TG1 cells not expressing cytSkp or
cytFkpA was used as negative control (lane 1).
15R. Levy et al. / Journal of Immunological Methods 394 (2013) 10–2110 mM HEPES, 150 mM NaCl, 3 mM EDTA, 0.05% Surfactant
P20 at pH 7.4 with 1 mg/ml BSA (Sigma)), and filtered through
0.22 μ multiscreen GV filter plates (Millipore). Filtered peri-
plasmic extracts were injected over immobilized ligand for
3 min at 30 μl/min. Dissociation was followed for 10 min. The
surface was regenerated following each analyte injection with
10 mM glycine at pH 1.7. Data was double referenced by
subtracting the reference spot within the flow cell which was
an activated and deactivated blank surface, as well as sub-
tracting out blank injections. Following referencing, the data
were fit to a 1:1 dissociation model using Biacore 4000 eval-
uation software.
3. Results
3.1. Expression of Skp and FkpA in the E. coli cytoplasm
To express Skp and FkpA in the E. coli cytoplasm, DNAs
encoding these chaperones lacking their signal sequences and
containing V5 and FLAG tags, respectively, were amplified by
PCR from the XL1-Blue E. coli chromosome. The gene products,
designated as cytSkp-V5 and cytFkpA-FLAG, were cloned into
the L-arabinose-inducible expression vector, pAR3 (Perez-Perez
andGutierrez, 1995) either separately (Fig. 1a), or as a bicistronic
gene sequence cyt[Skp + FkpA] encoding both cytFkpA and
cytSkp (Fig. 1b) for expression in the E. coli cytoplasm. Vectors
were also constructed containing Skp and FkpAwith their native
signal sequences for expression in the E. coli periplasm (Fig. 1a).
Plasmids containing cytSkp-V5 and/or cytFkpA-FLAG, were
transformed into E. coli TG1 cell cultures, grown to log phase,
induced with L-arabinose, and periplasmic and cytoplasmic
extracts prepared. Western blot analysis using anti-V5 and
anti-FLAG tag antibodies verified that cytSkp and cytFkpA
expressed on the same or separate plasmids were produced in
the cytoplasmof TG1 cells (Fig. 2, Lanes 3 and 5). Lower amounts
of cytSkp and cytFkpA also were observed in an E. coli peri-
plasmic extract (Fig. 2, Lanes 2 and 4) which may be due to
escape of the chaperones through the inner membrane during
the generation of the extracts. The two bands that appear upon
overexpression of cytSkp in E. coli (Fig. 2b) could be attributed to
an incomplete processing of Skp corresponding to the precursor
and mature forms of Skp. Other scientists have previously
demonstrated similar results when probing Skp using anti-Skp
antisera (Volokhina et al., 2011).
3.2. Enhancement by chaperones of Fab secretion into the E. coli
periplasm
We first tested the effect of co-expressing FkpA and Skp
on secretion into the bacterial periplasm of Fabs containing
kappa light chains. Initially, two human kappa Fabs, ING1
(anti-EpCAM) and XPA23 (anti-IL1β) and a murine anti-
human insulin receptor kappa Fab, 83-7 (Soos et al., 1986)
were expressed in TG1 cells in the presence or absence of
cytoplasmically or periplasmically-expressed FkpA or Skp,
either aloneor in combination. The level of Fab in the periplasm
capable of binding to EpCAM and IL1β was assessed by ELISA.
The results of this experiment demonstrate that the expression
of functional ING1 and XPA23 Fabs was increased when
co-expressed with cytFkpA (Fig. 3a, b, fifth dark gray column
from the left). By contrast, with the exception of the conditionin which it was co-expressed with cytFkpA, most of the XPA23
Fab expressedwith orwithout chaperones was non-functional,
as evidenced by the low amount of binding in the target-
specific ELISA (ELISA absorbance at 450 nm was less than 0.1).
The amount of functional murine 83-7 Fab expressed in the
periplasm, assessed by target ELISAs (Fig. 3c, dark gray columns)
was improved when co-expressed with cytFkpA (Fig. 3c, fifth
set of columns from the left). Since the above results dem-
onstrated that co-expression with cytFkpA and, in very few
cases, cyt[Skp + FkpA] provided the greatest benefit for Fab
secretion, we evaluated the effects of these chaperones on two
additional human kappa Fabs, BM7-2 and CF1, which bind a
human tyrosine kinase and Tie-1, respectively. Total and func-
tional amounts of BM7-2 or CF1 Fab in the periplasm were
measured by expression (Fig. 4, light gray columns) and target
(Fig. 4, dark gray columns) ELISAs, respectively. The cytFkpA
chaperone construct improved the functional BM7-2 and CF1
Fab expression (Fig. 4a and b, respectively), but to a lesser
extent than XPA23 or ING1 Fabs.
Unlike kappa light chains, lambda light chains do not
contain framework proline residues in the cis conformation.
Since in addition to its catalytic proline isomerization activity,
FkpA functions as a molecular chaperone, we measured levels
of total and functional gastrin-specific Fabs, C10, D1, and E6,
which contain lambda light chains, co-expressed with cytFkpA
or cyt[Skp + FkpA]. The benefit of cytFkpA expression on
secretion of functional Fabs containing lambda light chainswas
less apparent than with kappa Fabs in that C10, D1, and E6 Fab
periplasmic expression did not benefit from co-expression
with cytFkpA (Fig. 5). It appears that simultaneous expression
of cytSkp and cytFkpA decreased the expression of C10, D1, and
E6 Fabs (Fig. 5) possibly due to negative influence of Skp
expression in the bacterial cytoplasm.
Fab expression also can be quantified by SPR by first
capturing Fab fragments with anti-human Fab antiserum
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Fig. 3. Effect of co-expression of cytoplasmically produced chaperones
cytSkp and cytFkpA generated alone or together (cyt[Skp + FkpA]) or effect
of their periplasmically expressed counterparts Skp, FkpA, and [Skp + FkpA]
on the accumulation of (a) ING1, (b) XPA23, and (c) 83-7 Fabs in the
periplasm of E. coli TG1 cells. Cells harboring only the empty plasmid pAR3
were used as negative control. Cells were grown and induced as described in
the Materials and methods section. The concentration of functional Fabs
(dark gray columns) and the total amount of soluble periplasmic Fab (light
gray columns) were monitored by ELISA. Binding is represented as fold over
absorbance (450 nm) of Fab alone with empty vector pAR3, in the absence
of chaperones. Error bars represent SEM values.
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Fig. 4. Effect of co-expression of the cytoplasmically produced chaperone
cytFkpA generated alone or together with cytSkp (cyt[Skp + FkpA]) on the
accumulation of the BM7-2 Fab (a) or the CF1 Fab (b) in the periplasm of
TG1 cells. Cells harboring only the empty plasmid pAR3 were used as
negative controls. Cells were grown and induced as described in the
Materials and methods section. The concentration of the total amount of
soluble periplasmic Fab (light gray columns) and functional (dark gray
columns) Fabs was monitored by ELISA. Binding is represented as fold over
absorbance (450 nm) of Fab alone with empty vector pAR3, in the absence
of chaperones. Error bars represent SEM values.
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Fig. 5. Effect of co-expression of the cytoplasmically produced chaperone
cytFkpA generated alone or together with cytSkp (cyt[Skp + FkpA]) on the
accumulation of the anti-gastrin lambda chain containing C10, D1, and E6
Fabs in the periplasm of TG1 cells. Cells harboring only the empty plasmid
pAR3 were used as negative controls. Cells were grown and induced as
described in the Materials and methods section. The concentration of the
total amount of soluble periplasmic Fab (light gray columns) and functional
(dark gray columns) Fabs was monitored by ELISA. Binding is represented as
fold over absorbance (450 nm) of Fab alone with empty vector pAR3, in the
absence of chaperones.
16 R. Levy et al. / Journal of Immunological Methods 394 (2013) 10–21immobilized on a Biacore sensor chip. For this study, we
tested levels of Fab in the periplasm upon co-expression with
the chaperone constructs that generated more substantial
expression improvements based on ELISA results. To quantify
Fab levels, a standard curve was generated using a control
human Fab; periplasmic Fab concentrations were estimated
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Fig. 6. Effect of co-expression of cytFkpA in the cytoplasm of TG1 cells on the
accumulation of ING1 Fab in the periplasm when both proteins are
expressed from a single tricistronic vector under the influence of the lac
promoter. (a) The concentrations of the total amount of soluble periplasmic
Fab (light gray columns) and functional (dark gray columns) amounts of
periplasmic Fab were monitored by ELISA in the presence or absence of
cytFkpA. Binding is represented as fold over absorbance (450 nm) of Fab
alone, in the absence of chaperones. Growth and induction conditions of
TG1cells were described in the Materials and methods section. (b) Relative
amounts of total ING1 Fab were estimated by SPR using the Biacore
BIAevaluation software and expression is represented as fold over concen-
tration of ING1 Fab in the absence of chaperones. Periplasmic extracts of TG1
cells served as a negative control. Biacore was performed on periplasmic
extracts of ING1 Fab captured by F(ab′)2-specific anti-human IgG
immobilized on the surface of a CM5 sensor chip. Error bars represent SEM
values.
17R. Levy et al. / Journal of Immunological Methods 394 (2013) 10–21based on SPR resonance units (RUs) in relation to the standard
curve (see Table 1). Since the kappa Fab fragments used in this
study share identical constant regions, the affinity of the
secondary antibodies used to detect the Fabs should be very
similar. Cytoplasmic expression of cytFkpA resulted in 5.3 to
7.6-fold and 5.5 to 26-fold increases in production of XPA23
and ING1 (kappa) Fabs, respectively, in the periplasm com-
pared to the same antibodies without cytFkpA. As observed by
ELISA (Fig. 4), expression of the CF1 kappa Fab benefited to a
lesser extent (1.7 to 2-fold) from expression of cytFkpA.
3.3. Co-expression of cytFkpA and Fab on a single plasmid
A tricistronic vector (Fig. 1b) was developed for co-
expressing the ING1 Fd and light chains in the periplasm
along with cytFkpA under control of the lac promoter.
Western blot analysis confirmed that most of the cytFkpA
was expressed in the cytoplasm (data not shown). Accumu-
lation of total and functional Fabs in the periplasm, assessed
by expression and target ELISAs, was improved when co-
expressed with cytFkpA (Fig. 6a), thus establishing the
usefulness of incorporating cytFkpA along with Fd and light
chains as a tricistronic unit in the expression vector. We also
confirmed by SPR that total periplasmic ING1 Fab was
increased by co-expressing with cytFkpA from a single vector
in the E. coli cytoplasm (Fig. 6b). Yields of periplasmic soluble
Fab ranged from 0.4 to 2.45 μg/ml without cytFkpA and 3.5–
14.2 μg/ml in the presence of cytFkpA.
3.4. Expression of cytFkp increases hit diversity and expression
from panning phage display libraries
Since co-expression of cytFkpA enhances expression in the
E. coli periplasm of functional Fabs with kappa (and some
lambda) light chains, we examined the effects of co-expressing
cytFkpA on selection of antigen-specific Fab or scFv fragments
from naïve phage display libraries. Three rounds of phage
panning were performed with biotinylated target (kinase)
using a large kappa scFv library (Schwimmer et al., 2013).
Following the third round of panning, clones were picked for
evaluation of scFv expression in the periplasm. Periplasmic
extracts were also tested for binding to kinase. Panning was
performed with or without expression of cytFkpA from a
separate arabinose-inducible vector (pAR3) containing a p15A
origin of replication which is compatible with the libraryTable 1
Estimate of periplasmic Fab protein yields measured by Surface Plasmon Resonance
Fab Experiment # Light
chain
Chaperone
co-expressed
Periplasm
(no chap
XPA23 1 Kappa cytFkpA 0.74
XPA23 2 Kappa cytFkpA 0.30
ING1 1 Kappa cytFkpA 0.02
ING1 2 Kappa cytFkpA 0.13
CF1 1 Kappa cytFkpA 1.44
CF1 2 Kappa cytFkpA 0.81
a Calculation of Fab yields was based on Fab capture by anti-human IgG (Fab spec
in the Materials and methods section. Concentration measurements were based on s
performed in singlicate using Biacore A4000. Experiment 2 represents two independ
Biacore 2000. Experiments 1 and 2 used two different periplasmic extract preparat
improvements between different experiments maybe attributed to the low accur
different efficiencies of periplasmic extract preparations.phagemid vector that carries the lac promoter and harbors the
ColE1 origin of replication.
Ninety three output clones were selected after the third
round of phage panning performed with or without cytFkpA(SPR).a
ic yield
erone) (μg/ml)
Periplasmic yield
(with chaperone) (μg/ml)
Improvement (%)
5.52 646
2.03 577
0.10 400
0.55 323
2.39 66
1.50 85
ific) immobilized on a high density Biacore A4000 or 2000 chip, as described
tandard curves made with serial dilutions of a human Fab. Experiment 1 was
ent measurements (A and B) performed in triplicate using three flow cells on
ions (details in Supplementary figures and tables). Variations of expression
acy of Biacore measurements when Fab concentrations are very low or to
18 R. Levy et al. / Journal of Immunological Methods 394 (2013) 10–21expression. While scFv clones selected from panning campaigns
without cytFkpA were induced only with IPTG, clones selected
from panning with cytFkpA also were induced with L-arabinose
to allow cytFkpA expression. The amount of functional scFv in
the bacterial periplasmic extracts in the absence and presence of
cytFkpA was assessed by ELISA. Overexpression of cytFkpA
significantly increased both the frequency and expression levels
of sequence-unique clones obtained by panning with a scFv
phage display library containing kappa light chains (Table 2).
Only 10% of the output clones selected from panning without
cytFkpA were sequence-unique and antigen-specific, with an
ELISA signal (OD450) greater than 3-fold over the background,
compared to 48% of clones selected when cytFkpA was co-
expressed. Thus, the diversity of the selected kinase-binding
clones, as defined by the number of sequence-unique clones and
their expression levels, was greatly improved in the presence of
cytFkpA.
To confirm the cytFkpA expression benefit for phage hit
diversity and expression, two arms of panning with and
without cytFkpA were performed against the Tie-2 antigen
using a Fab phage display library containing similar kappa and
lambda light chain representation (Schwimmer et al., 2013).
Periplasmic extracts of 93 selected clones from each of the
panning armswere screened by ELISA for binding to Tie-2. Hits
from panning with cytFkpA appeared to express much better,
as 43% of the output clones were sequence unique and
generated an ELISA signal greater than 3-fold above back-
ground (including 16% at more than 12-fold over background);
without cytFkpA expression, only 16% of the output clones
bound to Tie-2 with a signal greater than 3-fold over the
background (including 5% more than 12-fold above back-
ground) (Table 2). Thus, panning with cytFkpA also enhanced
the diversity of the Tie-2-specific selected Fab clones, generat-
ing a higher number of sequence-unique and better expressing
clones. In the presence or absence of cytFkpA, the percentage of
kappa vs. lambda Tie-2 binding clones remained virtually
unchanged (30% kappa and 70% lambda). However, there was
a 2.5–3.3-fold increase of the number of both kappa and
lambda-containing sequence-unique Tie-2 binding clones in
thepresence of cytFkpA (4kappa and11 lambda cloneswithout
expression of cytFkpA, as opposed to 13 kappa and 27 lambda
clones in the presence of cytFkpA).Table 2
Selection of scFv or Fab antibody candidates with the presence or absence of
cytFkpA.a
Antibody
clones
Library
panned
cytFkpA
(+/−)
Unique binding clones
over background (%)
Total unique
binding clones
(%)
3-fold 6-fold 12-fold
Kinase scFv − 9 1 0 10
scFv + 26 22 0 48
Tie-2 Fab − 8 3 5 16
Fab + 9 18 16 43
a Binding of periplasmic extracts to kinase or biotin-Tie-2 antigens was
measured by ELISA, as described in the Materials and methods section.
Clones were selected following panning against kinase or biotinylated-Tie-2
targets using a scFv phage library containing only kappa light chains or a Fab
phage library with both kappa and lambda light chains. Panning and
screening were performed in the absence or presence of cytFkpA.3.4.1. Effect of cytoplasmic cytFkpA expression on Fab fragment
display on phage
Wecompared the Fab fragment display levels onM13phage
in thepresence or absence of cytFkpA expression. E. coli TG1 cell
cultures expressing a Fab phagemid library with lambda or
kappa light chains were allowed to express with or without
cytFkpA. Following growth and induction, phage were rescued
and precipitated after 25 h to assess Fab display levels. The
relative amount of phagewas estimated through phage capture
of serial dilutions on ELISA plates coated with M13-specific
polyclonal antibodies and detection with anti-M13 antibodies
conjugated with HRP. Fab display levels of the M13-captured
dilutions were determined using anti-V5 antibodies that
recognize theC-terminal V5 tag on the displayed Fab fragments.
The ratio of the inverse EC50 of the two ELISAs provided a direct
indication of the number of phage displaying Fab fragments.
Comparing the ratios of phage rescue (Fig. 7) clearly showed
that rescues performedwith both kappa and lambda libraries in
the presence of cytFkpA had greater than 3.5-fold increase in
display than rescues performed in the absence of cytFkpA.3.4.2. Effect of cytFkpA expression on dissociation rates of
selected clones
Since co-expression with cytFkpA facilitates improved
selection of unique functional clones from phage display
libraries, we evaluated the dissociation kinetics of scFv or Fab
clones selected by phage display against the kinase (Fig. 8a)
and Tie-2 targets (Fig. 8b) using SPR. Periplasmic extracts of
anti-kinase scFv or anti-Tie-2 Fab fragments were allowed to
bind to Biacore chips coated with anti-V5 antibodies (for
kinase detection) or Tie-2 ligand, respectively. The results of
this experiment (Fig. 8) demonstrate that co-expression of
cytFkpA during phage panning allowed selection of a greater
number of sequence-unique clones with slower dissociation
rates (kd values lower than 10−3 1/s are represented by
columns higher than the horizontal dashed line in Fig. 8).
This effect was most pronounced for anti-kinase candidates
from the scFv phage display kappa-only library where 8 of 26
clones selected via panning in the presence of cytFkpA had kd
values lower than 10−3 1/s, as compared to none panned
without cytFkpA.0
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Fig. 7. Relative display of kappa (K) and lambda (L) Fabs on phage produced
in TG1 cells with or without cytFkpA. Samples were taken 25 (K25, L25)
hours after helper phage infection. Values are displayed relative to kappa or
lambda library rescues in TG1 cells, without cytFkpA, at 25 h after infection.
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Fig. 8. Dissociation rates (kd) of sequence-unique scFv or Fab library clones selected by phage display against kinase using a scFv phage library (a) or Tie-2 using a
Fab library (b) in the presence (dark gray columns) or absence (light gray columns) of cytFkpA. Periplasmic extracts of anti-kinase scFv or anti-Tie-2 Fab clones
were allowed to bind to Biacore sensor chips capturing anti-V5 antibodies or Tie-2 ligand, respectively. A horizontal dashed line emphasizes clones with kd values
lower than 10−3 s−1. Clones with too-fast-to-measure kd values are not shown.
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In studies reported here, we demonstrate that cytoplasmic
expression of the periplasmic chaperone, peptidyl prolyl cis-
trans isomerase, FkpA, improved the secretion of functional
antibody fragments into the bacterial periplasm. The benefit of
the cytoplasmically-expressed chaperone exceeded that of
native FkpA expressed in the periplasm. We also report an
improvement in periplasmic expression of functional Fab for all
the tested antibody fragments containing kappa light chains
co-expressed with cytoplasmic FkpA. By comparison, cytoplas-
mic expression of FkpA did not benefit secretion of antibody
fragments containing lambda light chains to the same degree.
The results observed with antibody fragments containing
kappa versus lambda light chains suggest that the PPIase
activity of cytFkpA may play a major role in the enhancement
of functional antibody fragment secretion into the periplasm
since only kappa light chains carry cis-prolines.
Pluckthun et al. have shown that co-expression of full-
length FkpA in the periplasm can also improve the yields of
scFv fragments without cis-prolines (i.e. lambda light chains),
establishing the usefulness of the FkpA molecular chaperonedomain (Ramm and Pluckthun, 2000). Our results show that
themolecular chaperone activity of cytSkp by itself is unable to
improve secretion of functional ING1 and XPA23 Fab frag-
ments, suggesting that the cis-trans peptidyl prolyl isomerase
activity of cytFkpA in the E. coli cytoplasm is instrumental for
these kappa antibody fragments prior to their transport into
the oxidizing environment of the periplasm where formation
of intra-chain and interchain disulphide bonds takes place.
Thus, the cytoplasmic localization of the PPIase activity of
cytFkpA could explain our results. In our studies, we employed
leader peptides that enable periplasmic localization of antibody
fragments through the Sec secretion pathway. The Sec route
allows transmembrane transport of proteins into the periplasm
in a loosely folded or unfolded, translocationally competent
state or insertion into the cytoplasmic membrane through the
SecYEG apparatus (Natale et al., 2008; Dalal and Duong, 2011;
Zalucki et al., 2011). We can speculate that cytFkpA isomerizes
key prolines of kappa light chains prior to the periplasmic
export, and by doing so removes a folding bottleneck following
the translocation of the heterologously expressed polypeptides
into the periplasm. To further validate our hypothesis, ad-
ditional studies should be performed utilizing a variant of
20 R. Levy et al. / Journal of Immunological Methods 394 (2013) 10–21cytFkpA that lacks the chaperone activity but retains the
domain with peptidyl prolyl isomerase activity. Such a variant
would have to be tested to determine whether cytoplasmic
expression still confers the beneficial secretion-enhancing
effects of full-length cytFkpA.
As a consequence of the inability of overexpressed heterol-
ogous proteins to fold properly in a timely fashion, misfolded
proteins can be deposited in the form of cytoplasmic or
periplasmic inclusion bodies or they can be driven towards
degradation (Georgiou et al., 1986; Betton et al., 1998; Baneyx
and Mujacic, 2004) Therefore, we isolated insoluble fractions of
E. coli cells expressing XPA23 or ING1 Fabs, in the absence of
cytFkpA, but we were unable to detect any Fab species by
Western blot analysis (unpublished data), suggesting that no
Fab was localized in inclusion bodies. Thus, we cannot support
the notion that co-expression of cytFkpA increases the amount
of functional Fab by means of improving its solubility. We
hypothesize that misfolded or unfolded antibody fragment
species serve as substrates for proteolytic degradation, instead
of associating into inclusion bodies.
We also demonstrate that co-expression of cytFkpA togeth-
erwith the kappa light chain-containing ING1 Fab expressed on
a single tricistronic vector results in an improvement of func-
tional Fab secretion relative to expression in the absence of
cytFkpA. Similarly, it previously was shown that the amounts of
single chain antibodies expressed in the periplasm of E. coli
upon the co-expression of Skp were also increased when
expression of both proteinswas driven from a dicistronic vector
(Hayhurst and Harris, 1999).
After observing the benefit of cytFkpA co-expression on Fab
secretion, we evaluated its contribution to the antibody dis-
covery process by incorporating the same expression platform
with cytFkpA into phage panning selection and screening
assays. The isolation of ideal lead candidates requires the
design of methodologies allowing efficient screening of the
libraries and exploitation of the vast repertoire of different
library members. The choice of antibody formats (mostly scFv
and Fab), the protein expression yields, the sequence diversity,
the levels of display (i.e. on phage or yeast), and the ease and
quality of in vitro screening are just a few of the factors that can
impact the quality of antibody libraries (Mondon et al., 2008).
In fact, it can be increasingly challenging to design screening
assays that allow the identification of high-affinity library
members and distinguish them from high-expressing clones
since they are both able to display efficiently. Poorly expressed,
functional library members are underrepresented and as a
consequence, fail to be selected during screening. Thus, it is of
paramount importance to maximize the solubility and func-
tional expression of antibody library members.
Our studies revealed that co-expression of cytFkpA in the
bacterial cytosol improves the level of display of Fab or scFv
phage fragments, thus promoting discovery of antibody can-
didates that otherwise would not be selected. The enhance-
ment of phage display likely drives selection of a more diverse
repertoire of target-binding clones, as we observed experi-
mentally, which may lead to the discovery of higher affinity
clones with the desired functional properties. The distribution
of off-rate values did not differ following selections in the
presence of cytFkpA. However, the larger number of sequence-
unique antibody clones that we discovered in the presence of
cytFkpA could increase the probability of selecting clones withhigher affinity. In contrast to our observations with expression
of individual Fab fragments, phage panning in the presence of
cytFkpA improved the diversity of both lambda and kappa scFv
and Fab libraries, resulting in a higher number of antigen-
binding clones with unique sequences and/or improved dis-
sociation constants (Table 2 and Fig. 8). This improvement can
be attributed to the elevated numbers of phage displaying
antibody fragments that we observed in the presence of
cytFkpA expression (Fig. 7). Since the improvement in diversity
was observed for selection of both lambda and kappa antibody
fragments,we conclude that both the peptidyl prolyl isomerase
and molecular chaperone activities of cytFkpA are important
contributors to selection of antibodies from phage libraries.
In our work, we obviate the use of mutant bacterial strains
by expressing chaperones in the bacterial cytoplasm while we
continue to express antibody fragments in the periplasm, which
has frequently served as the standard milieu for heterologous
protein expression in E. coli. Previous studies have co-expressed
chaperones in the E. coli cytoplasm (e.g. the trigger factor which
is a PPIase, like FkpA, that possesses distinct molecular chap-
erone and enzymatic activities) (Hesterkamp and Bukau, 1996;
Lee and Bernstein, 2002) and improved the production of
antibody fragments in the cytoplasm of E. coli. However, in these
cases, expression had to be limited to the oxidative cytoplasm of
trxBgor mutant E. coli strains to allow the formation of the
disulphide bonds of the antibody fragments (Levy et al., 2001;
Heo et al., 2006). Overexpression of cytoplasmic chaperones (i.e.
the GroES/L chaperonin system, DnaKJE) (Duenas et al., 1994;
Hu et al., 2007) or periplasmic chaperones (i.e. FkpA) (Bothmann
and Pluckthun, 2000; Ramm and Pluckthun, 2000) in their
natural E. coli environment (cytoplasm or periplasm) has been
employed successfully to enhance the production yields of
functional scFv fragments and has been extensively reviewed in
the past (Wall and Pluckthun, 1995; Kolaj et al., 2009). In
contrast to these studies, our work reports the use of cytFkpA
and cytSkp in the E. coli cytoplasm, while their native coun-
terparts, FkpA and Skp, are normally localized in the bacterial
periplasmic space.
We also demonstrate that co-expression of cytFkpA in the
cytoplasm improves the functional protein yields of the anti-
EpCAM ING1 and anti-IL1β XPA23 Fab fragments in the
periplasm. When expressed alone, these Fabs express poorly
(Table 1). Low periplasmic expression can be attributed to cell
toxicity issues often resulting from poor translocation across
the inner E. coli membrane and/or aggregation in the peri-
plasm. Therefore, our results are consistent with previous
studies that showed more apparent beneficial effects of FkpA
on the functional expression of toxic scFv antibody fragments
(Bothmann and Pluckthun, 2000). Interestingly, a recent study
suggested that overproduction of FkpA, and to a lesser extent
Skp, in E. coli enhances the viability of cells by elevating the
expression of genes encoding heat-shock proteins or proteins
leading to responses to misfolded protein stress (Ow et al.,
2010). It remains to be seen if the cell viability is also improved
when cytFkpA is co-expressed in the bacterial cytoplasm. The
same group reported that co-production of FkpA together with
Skp in the periplasm not only increases the solubility and
secretion of a scFv to the extracellular medium, but also
improves the cell viability.
A major advantage of our approach is that the native
sequences of Fabs or scFvs do not have to be altered. This
21R. Levy et al. / Journal of Immunological Methods 394 (2013) 10–21approach is in contrast to previous efforts that employ protein
engineering techniques to optimize the sequence of antibody
fragments by either introducing mutations to increase their
solubility (i.e. by generating cysteine-free mutants allowing
expression in the cytoplasm without the requirement for
refolding) (Proba et al., 1998; Worn and Pluckthun, 1998), or
by using fusion proteins (Bach et al., 2001; Jurado et al., 2006).
In conclusion, co-expression of the chaperone variant,
cytFkpA, offers multiple benefits over alternative approaches
for the selection of novel antibody candidates or the optimiza-
tion of production of existing antibody fragments. Based on the
results reported here, the novel expression platform we
describe in this work is a useful tool for phage display and
recombinant antibody manufacturing.
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